= Emerging. More than 5 years before clinical availability. (24.37%, 2023)
= Expected to be clinically available in 1 to 4 years. (39.50%, 2023)
= Clinically available now. (36.13%, 2023)
No entry found.
Financial Disclosure
Description
Y/N
Source
Grants
no
Salary
no
Board Member
no
Stock
no
Expenses
no
IP Royalty
no
Planning to mention or discuss specific products or technology of the company(ies) listed above:
no